StockData
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) stock

ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 7/30
$270.33−0.86 (-0.32%)

Close on Nov 18, 2026Market cap $16.75BP/E 22.2Yield –

Ascendis Pharma A/S shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Ascendis Pharma A/S's shares outstanding was 68M at Jun 30, 2026. For fiscal 2025 it was 61M, up 4.7% from the year before. Over ten years it grew 9.8% a year on average. The highest annual figure on record is 61M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202561M+4.7%
FY2024Dec 31, 202458M+2.9%
FY2023Dec 31, 202356M+0.4%
FY2022Dec 31, 202256M+2.4%
FY2021Dec 31, 202155M+8.2%
FY2020Dec 31, 202051M+8.8%
FY2019Dec 31, 201947M+13.2%
FY2018Dec 31, 201841M+22.2%
FY2017Dec 31, 201734M+26.6%
FY2016Dec 31, 201627M+11.8%
FY2015Dec 31, 201524M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202668M+6.9%
Q1 FY2026Mar 31, 202665M+7.5%
Q4 FY2025Dec 31, 202561M+2.3%
Q3 FY2025Sep 30, 202561M+5.6%
Q2 FY2025Jun 30, 202564M+5.1%
Q1 FY2025Mar 31, 202560M+5.5%
Q4 FY2024Dec 31, 202460M+5.7%
Q3 FY2024Sep 30, 202458M+2.2%
Q2 FY2024Jun 30, 202461M+8.2%
Q1 FY2024Mar 31, 202457M+1.4%
Q4 FY2023Dec 31, 202357M+1.1%
Q3 FY2023Sep 30, 202356M+0.8%
Q2 FY2023Jun 30, 202356M+0.7%
Q1 FY2023Mar 31, 202356M-1.1%
Q4 FY2022Dec 31, 202256M-1.6%
Q3 FY2022Sep 30, 202256M+2.2%
Q2 FY2022Jun 30, 202256M+3.6%
Q1 FY2022Mar 31, 202257M+5.5%
Q4 FY2021Dec 31, 202157M+6.2%
Q3 FY2021Sep 30, 202155M+3.7%
Q2 FY2021Jun 30, 202154M+11.7%
Q1 FY2021Mar 31, 202154M+12.0%
Q4 FY2020Dec 31, 202054M+11.9%
Q3 FY2020Sep 30, 202053M+10.8%
Q2 FY2020Jun 30, 202048M+2.2%
Q1 FY2020Mar 31, 202048M+10.6%
Q4 FY2019Dec 31, 201948M+13.7%
Q3 FY2019Sep 30, 201948M+13.6%
Q2 FY2019Jun 30, 201947M+13.3%
Q1 FY2019Mar 31, 201943M+12.1%
Q4 FY2018Dec 31, 201842M+13.8%
Q3 FY2018Sep 30, 201842M+28.5%
Q2 FY2018Jun 30, 201842M+28.1%
Q1 FY2018Mar 31, 201839M+19.3%
Q4 FY2017Dec 31, 201737M–
Q3 FY2017Sep 30, 201733M–
Q2 FY2017Jun 30, 201733M–
Q1 FY2017Mar 31, 201732M–

More Ascendis Pharma A/S figures

See a number that looks wrong?